5[1]β-Blocker Heart Attack Study Group. The β-blocker heart attack trail[J]. JAMA, 1981, 246: 2073-4.
6[2]Viskin S, Kitzis I, Lev E, et al. Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trails to clinical practice[J]. J Am Coll Cardiol, 1995, 25: 1327-32.
7[3]Szabo BM, Crijms HJ, Wiesfeld AC, et al. Predicfors of mortality in patients with sustained ventricular tachycardias or ventricular fibrillation and depressed left ventricular function, importance of β-blockade[J]. Am Heart J, 1995, 130: 281-6.
8[4]Scheinman MM, Levine JH, Cannom DS, et al. Doseranging study of intravenous amiodarone in patients with life-threatenning ventricular tachyarrhythmias[J]. Circulation, 1995, 92(11): 3264-72.
9[5]Levine JH, Massumi A, Scheinman MM, et al. Intravenous amiodarone for recurrent sustained hypoteusive ventricular tachyarrhythmias[J]. J Am Coll Cardiol, 1996, 27(1): 67-75.
10Zipes D P,Camm A J,Borggrefe M,et al.ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death:a report of the american college of cardiology/american heart association task force and the european society of cardiology committee for practice guidelines[J].J Am Coll Cardiol,2006,48(5):247-346.
9Zipes D P,Camm A J,Borggrefe M,et al.ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death:a report of the american college of cardiology/american heart association task force and the european society of cardiology committee for practice guidelines[J].J Am Coll Cardiol,2006,48(5):247-346.
10Deharo J C,Mouliom F,Salamand A,et al.Role of antiarrhythmic drugs in reducing the number of defibrillation shocks[J].Arch Mal Coeur Vaiss,2005,98(2):140-144.
